Vaccine preventable diseases |
Age restrictions and other conditions specific to the vaccine |
Cholera |
Not permitted |
COVID-19 |
5 years and over
For 5 to 10 years and over old: pharmacist must have additional paediatric authorisation with the Tasmanian Dept of Health |
Diphtheria |
10 years and over
diphtheria-tetanus-acellular pertussis (dTpa) combination vaccine only |
Haemophilus influenzae type b |
Not permitted |
Hepatitis A |
10 years and over
Vaccination for those recommended, but not funded, to receive Hepatitis A vaccination unrelated to travel |
Hepatitis B |
10 years and over
Excludes vaccination for travel (including to endemic regions) and vaccination for post-exposure prophylaxis |
Herpes Zoster |
18 years and over
Shingrix® only |
Human Papillomavirus |
10 years and over
Catch-up vaccination limited to persons requiring a single dose only |
Influenza |
5 years and over
For 5 to 10 years and over old: pharmacist must have additional paediatric authorisation with the Tasmanian Dept of Health |
Japanese encephalitis |
Not permitted* |
Measles
Mumps
Rubella |
10 years and over
Vaccination for catch-up funded under the NIP, including combination products (e.g., measles , mumps, rubella and varicella) |
Meningococcal (ACWY) |
10 years and over
Vaccination of individuals funded under the NIP and people recommended (not funded) for MenACWY vaccination |
Meningococcal B |
10 years and over
Vaccination for those recommended to receive a Meningococcal B vaccination unrelated to travel, not funded under the NIP |
Mpox |
Not permitted |
Pertussis |
10 years and over
diphtheria-tetanus-acellular pertussis (dTpa) combination vaccine only |
Pneumococcal |
10 years and over
Refer to the Pneumococcal Vaccination Schedule decision tree when considering vaccination |
Poliomyelitis |
10 years and over
Including in combination products with other antigens |
Q Fever |
Not permitted |
Rabies and other lyssaviruses |
Not permitted* |
Respiratory syncytial virus |
People aged 60 years and over (AREXVY® and ABRYSVO®)
Pregnant women 18 years of age and over (ABRYSVO® ONLY), recommended at 28-36 weeks gestation.
|
Rotavirus |
Not permitted |
Tetanus |
16 years and over
diphtheria-tetanus-acellular pertussis (dTpa) combination vaccine only
Excludes vaccination for tetanus prophylaxis related to wound management |
Tuberculosis |
Not permitted |
Typhoid |
Not permitted* |
Varicella (chickenpox) |
10 years and over
Including in combination products with other antigens |
Yellow Fever |
Not permitted |